questionsmedicales.fr
Composés chimiques organiques
Hydrocarbures
Hydrocarbures cycliques
Hydrocarbures aromatiques
Dérivés du benzène
Composés benzyliques
Composés benzyliques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Exposition professionnelle
Tests biologiques
Analyse sanguine
Analyse urinaire
Marqueurs biologiques
Métabolites
Évaluation des risques
Conditions de travail
Symptômes
5
Irritation cutanée
Maux de tête
Allergies
Réactions cutanées
Troubles neurologiques
Problèmes respiratoires
Enfants
Troubles du comportement
Prévention
5
Prévention
Équipements de protection
Réglementations
Industrie
Travailleurs
Formations de sécurité
Évaluations de risque
Entreprises
Sensibilisation
Campagnes d'information
Traitements
5
Intoxication
Soins symptomatiques
Antidotes
Traitement symptomatique
Irritations cutanées
Crèmes apaisantes
Complications
5
Complications
Troubles respiratoires
Cancers
Exposition prolongée
Gestion des complications
Suivi médical
Effets à long terme
Santé
Facteurs de risque
5
Facteurs de risque
Industrie chimique
Mode de vie
Produits chimiques
Travailleurs de la santé
Médicaments
Environnements industriels
Laboratoires
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés benzyliques : Questions médicales les plus fréquentes",
"headline": "Composés benzyliques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés benzyliques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-26",
"dateModified": "2025-02-20",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés benzyliques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dérivés du benzène",
"url": "https://questionsmedicales.fr/mesh/D001555",
"about": {
"@type": "MedicalCondition",
"name": "Dérivés du benzène",
"code": {
"@type": "MedicalCode",
"code": "D001555",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alcools benzyliques",
"alternateName": "Benzyl Alcohols",
"url": "https://questionsmedicales.fr/mesh/D001592",
"about": {
"@type": "MedicalCondition",
"name": "Alcools benzyliques",
"code": {
"@type": "MedicalCode",
"code": "D001592",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.200"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Alcool benzylique",
"alternateName": "Benzyl Alcohol",
"url": "https://questionsmedicales.fr/mesh/D019905",
"about": {
"@type": "MedicalCondition",
"name": "Alcool benzylique",
"code": {
"@type": "MedicalCode",
"code": "D019905",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.200.100"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Benzylamines",
"alternateName": "Benzylamines",
"url": "https://questionsmedicales.fr/mesh/D001596",
"about": {
"@type": "MedicalCondition",
"name": "Benzylamines",
"code": {
"@type": "MedicalCode",
"code": "D001596",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.210"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pargyline",
"alternateName": "Pargyline",
"url": "https://questionsmedicales.fr/mesh/D010293",
"about": {
"@type": "MedicalCondition",
"name": "Pargyline",
"code": {
"@type": "MedicalCode",
"code": "D010293",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.210.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Bibenzyles",
"alternateName": "Bibenzyls",
"url": "https://questionsmedicales.fr/mesh/D001632",
"about": {
"@type": "MedicalCondition",
"name": "Bibenzyles",
"code": {
"@type": "MedicalCode",
"code": "D001632",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.308"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lignanes",
"alternateName": "Lignans",
"url": "https://questionsmedicales.fr/mesh/D017705",
"about": {
"@type": "MedicalCondition",
"name": "Lignanes",
"code": {
"@type": "MedicalCode",
"code": "D017705",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D02.455.426.559.389.140.450"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés benzyliques",
"alternateName": "Benzyl Compounds",
"code": {
"@type": "MedicalCode",
"code": "D001593",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Alexander P Atkins",
"url": "https://questionsmedicales.fr/author/Alexander%20P%20Atkins",
"affiliation": {
"@type": "Organization",
"name": "University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K."
}
},
{
"@type": "Person",
"name": "Alastair J J Lennox",
"url": "https://questionsmedicales.fr/author/Alastair%20J%20J%20Lennox",
"affiliation": {
"@type": "Organization",
"name": "University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K."
}
},
{
"@type": "Person",
"name": "Hiroaki Tsuji",
"url": "https://questionsmedicales.fr/author/Hiroaki%20Tsuji",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Motoi Kawatsura",
"url": "https://questionsmedicales.fr/author/Motoi%20Kawatsura",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp."
}
},
{
"@type": "Person",
"name": "Yan-Hong He",
"url": "https://questionsmedicales.fr/author/Yan-Hong%20He",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Cognitive profile in functional disorders.",
"datePublished": "2023-11-30",
"url": "https://questionsmedicales.fr/article/37889124",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13546805.2023.2275336"
}
},
{
"@type": "ScholarlyArticle",
"name": "[Uric acid, cognitive disorders, neurodegeneration].",
"datePublished": "2024-06-03",
"url": "https://questionsmedicales.fr/article/38829804",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.26442/00403660.2024.05.202698"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive subgroups and their longitudinal trajectories in bipolar disorder.",
"datePublished": "2022-06-25",
"url": "https://questionsmedicales.fr/article/35690884",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/acps.13460"
}
},
{
"@type": "ScholarlyArticle",
"name": "An evolutionary account of impairment of self in cognitive disorders.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36180662",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10339-022-01110-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cognitive impairment in bipolar disorder in comparison to mild cognitive impairment and dementia: a systematic review.",
"datePublished": "2023-02-20",
"url": "https://questionsmedicales.fr/article/34374270",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.47626/2237-6089-2021-0300"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés chimiques organiques",
"item": "https://questionsmedicales.fr/mesh/D009930"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hydrocarbures",
"item": "https://questionsmedicales.fr/mesh/D006838"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrocarbures cycliques",
"item": "https://questionsmedicales.fr/mesh/D006844"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hydrocarbures aromatiques",
"item": "https://questionsmedicales.fr/mesh/D006841"
},
{
"@type": "ListItem",
"position": 6,
"name": "Dérivés du benzène",
"item": "https://questionsmedicales.fr/mesh/D001555"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composés benzyliques",
"item": "https://questionsmedicales.fr/mesh/D001593"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés benzyliques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés benzyliques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-11",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés benzyliques",
"description": "Comment diagnostiquer une exposition aux composés benzyliques ?\nQuels tests sont utilisés pour détecter les composés benzyliques ?\nQuels symptômes indiquent une intoxication aux composés benzyliques ?\nY a-t-il des marqueurs biologiques pour les composés benzyliques ?\nComment évaluer le risque d'exposition aux composés benzyliques ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Cognition+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés benzyliques",
"description": "Quels sont les symptômes courants d'une exposition aux composés benzyliques ?\nLes composés benzyliques provoquent-ils des allergies ?\nQuels effets à long terme peuvent résulter d'une exposition ?\nLes symptômes varient-ils selon le type de composé ?\nComment les symptômes se manifestent-ils chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Cognition+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés benzyliques",
"description": "Comment prévenir l'exposition aux composés benzyliques ?\nY a-t-il des réglementations pour l'utilisation de ces composés ?\nQuels conseils donner aux travailleurs exposés ?\nLes entreprises doivent-elles effectuer des évaluations de risque ?\nComment sensibiliser le public aux dangers des composés benzyliques ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Cognition+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés benzyliques",
"description": "Quel traitement est recommandé en cas d'intoxication ?\nDes antidotes existent-ils pour les composés benzyliques ?\nComment traiter les irritations cutanées causées par ces composés ?\nLes traitements varient-ils selon l'âge du patient ?\nQuels soins d'urgence sont nécessaires en cas d'exposition aiguë ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Cognition+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés benzyliques",
"description": "Quelles complications peuvent survenir après une exposition prolongée ?\nLes composés benzyliques peuvent-ils causer des cancers ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le type de composé ?\nQuels sont les effets à long terme sur la santé ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Cognition+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés benzyliques",
"description": "Quels sont les principaux facteurs de risque d'exposition ?\nLes enfants sont-ils plus à risque d'exposition ?\nComment le mode de vie influence-t-il le risque d'exposition ?\nLes travailleurs de la santé sont-ils à risque ?\nQuels environnements présentent un risque accru ?",
"url": "https://questionsmedicales.fr/mesh/D001593?mesh_terms=Cognition+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une exposition aux composés benzyliques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les composés benzyliques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une intoxication aux composés benzyliques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des maux de tête, des nausées et des irritations cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs biologiques pour les composés benzyliques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des métabolites spécifiques peuvent être mesurés dans les fluides corporels."
}
},
{
"@type": "Question",
"name": "Comment évaluer le risque d'exposition aux composés benzyliques ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation des conditions de travail et des habitudes de vie est nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition aux composés benzyliques ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des irritations cutanées, des maux de tête et des vertiges."
}
},
{
"@type": "Question",
"name": "Les composés benzyliques provoquent-ils des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent développer des réactions allergiques aux composés benzyliques."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme peuvent résulter d'une exposition ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une exposition prolongée peut entraîner des troubles neurologiques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de composé ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la structure chimique et de la dose."
}
},
{
"@type": "Question",
"name": "Comment les symptômes se manifestent-ils chez les enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes plus graves, comme des troubles du comportement."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'exposition aux composés benzyliques ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle et suivre les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des réglementations pour l'utilisation de ces composés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réglementations strictes encadrent leur utilisation dans l'industrie et la recherche."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux travailleurs exposés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les formations de sécurité et signaler toute exposition suspecte immédiatement."
}
},
{
"@type": "Question",
"name": "Les entreprises doivent-elles effectuer des évaluations de risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les entreprises doivent régulièrement évaluer les risques liés à l'exposition."
}
},
{
"@type": "Question",
"name": "Comment sensibiliser le public aux dangers des composés benzyliques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Organiser des campagnes d'information et des formations sur les risques associés."
}
},
{
"@type": "Question",
"name": "Quel traitement est recommandé en cas d'intoxication ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend l'élimination de l'exposition et des soins symptomatiques."
}
},
{
"@type": "Question",
"name": "Des antidotes existent-ils pour les composés benzyliques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Comment traiter les irritations cutanées causées par ces composés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des crèmes apaisantes et éviter tout contact avec le composé irritant."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon l'âge du patient ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent être adaptés en fonction de l'âge et de la santé générale."
}
},
{
"@type": "Question",
"name": "Quels soins d'urgence sont nécessaires en cas d'exposition aiguë ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins d'urgence incluent le lavage des zones exposées et l'administration d'oxygène si nécessaire."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition prolongée ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des troubles respiratoires et des effets neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les composés benzyliques peuvent-ils causer des cancers ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien potentiel entre l'exposition prolongée et certains cancers."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications nécessite un suivi médical régulier et des traitements adaptés."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le type de composé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent varier en fonction de la structure chimique et de la dose."
}
},
{
"@type": "Question",
"name": "Quels sont les effets à long terme sur la santé ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets à long terme peuvent inclure des troubles neurologiques et des problèmes respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les principaux facteurs incluent le travail dans l'industrie chimique et l'utilisation domestique."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque d'exposition ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants sont plus vulnérables en raison de leur comportement exploratoire."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il le risque d'exposition ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie impliquant l'utilisation de produits chimiques augmente le risque d'exposition."
}
},
{
"@type": "Question",
"name": "Les travailleurs de la santé sont-ils à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs de la santé peuvent être exposés lors de l'utilisation de certains médicaments."
}
},
{
"@type": "Question",
"name": "Quels environnements présentent un risque accru ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les environnements industriels et de laboratoire présentent un risque accru d'exposition."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 20/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K.
Publications dans "Composés benzyliques" :
3 publications dans cette catégorie
Affiliations :
University of Bristol, School of Chemistry, Bristol, BS8 1TS, U.K.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, College of Humanities & Sciences, Nihon University, Sakurajosui, Setagaya-ku, Tokyo 156-8550, Japan. tsuji@chs.nihon-u.ac.jp kawatsur@chs.nihon-u.ac.jp.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Applied Chemistry of Chongqing Municipality, School of Chemistry and Chemical Engineering, Southwest University, Chongqing 400715, China.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Roy and Diana Vagelos Laboratories, Penn/Merck Laboratory for High-Throughput Experimentation, Department of Chemistry, University of Pennsylvania 231 South 34th Street Philadelphia Pennsylvania 19104-6323 USA pwalsh@sas.upenn.edu.
Department of Chemistry, Renmin University of China Beijing 100872 China 20050062@ruc.edu.cn.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Roy and Diana Vagelos Laboratories, Penn/Merck Laboratory for High-Throughput Experimentation, Department of Chemistry, University of Pennsylvania 231 South 34th Street Philadelphia Pennsylvania 19104-6323 USA pwalsh@sas.upenn.edu.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Roy and Diana Vagelos Laboratories, Penn/Merck Laboratory for High-Throughput Experimentation, Department of Chemistry, University of Pennsylvania 231 South 34th Street Philadelphia Pennsylvania 19104-6323 USA pwalsh@sas.upenn.edu.
Publications dans "Composés benzyliques" :
2 publications dans cette catégorie
Affiliations :
Department of Chemical Sciences, University of Johannesburg, PO Box 524, Auckland Park, 2006, Johannesburg, South Africa.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Kharagpur Kharagpur 721302 India mxb@iitkgp.ac.in.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Kharagpur Kharagpur 721302 India mxb@iitkgp.ac.in.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, Indian Institute of Technology Kharagpur Kharagpur 721302 India mxb@iitkgp.ac.in.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Liverpool, Liverpool, L69 7ZD, UK.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry, University of Liverpool, Liverpool, L69 7ZD, UK.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
1 publication dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an, 710119, China.
Publications dans "Composés benzyliques" :
Patients with functional disorders (FD) often experience cognitive problems such as forgetfulness and distractibility alongside physical symptoms that cannot be attributed to a known somatic disease....
Test scores of cognitive tests and psychiatric rating scales of 100 outpatients diagnosed with a functional disorder were compared to a control group (n = 300) of patients with other diagnoses and to ...
Out of the 100 patients with functional disorders, 59 reported significant subjective cognitive symptoms. A moderate difference (d = 0.5-0.7) was found between the FD group mean and the population mea...
The findings of the study suggest that a decline in processing speed is a central feature in the cognitive profile of patients with functional disorders....
This article examines the role of uric acid (UA) in cognitive changes and neurodegeneration, focusing on its functions as an antioxidant and prooxidant. Research suggests that changes in serum UA leve...
Cognitive functioning in bipolar disorder is heterogeneous with evidence for multiple subgroups. However, cognitive subgroup change patterns over time remains unknown. While prior work suggests minima...
Participants diagnosed with bipolar disorder (I, II, NOS; n = 568) and unaffected controls (n = 234) completed baseline, one- and five-year neuropsychological assessments. Data reduction techniques we...
Results were consistent with bipolar disorder participants forming three subgroups with high (n = 209), mid (n = 259), and low (n = 100) cognition. These groups were associated with unique clinical ch...
These results demonstrate that cognition-based subgroups of bipolar disorder participants have minimal differences in their longitudinal course in relation to each other and with unaffected controls....
Recent research has proposed that certain aspects of psychosis, as experienced in, e.g., schizophrenia (SCZ), but also aspects of other cognitive conditions, such as autism spectrum disorders (ASD) an...
To conduct a systematic review to describe cognitive abilities in bipolar disorder (BD) in comparison to cognitive abilities in mild cognitive impairment (MCI) and dementia....
A literature search was performed with no year or language restrictions. The search yielded 1,461 articles, with 1,261 remaining after removal of duplicates, five of which were suitable for the system...
Analyses from our systematic review showed that euthymic individuals with BD present impairments in cognitive domains such as attention and executive functioning, motor skills, conceptual thinking, an...
Findings from our systematic review suggest that cognitive impairments in euthymic BD fall into a range between the impairments seen in MCI and those seen in dementia. More studies are needed to analy...
Cognitive deficits are prevalent in bipolar disorder even during the euthymic phase, having a negative impact on global functioning and quality of life. As such, more and more mental health profession...
The aim of this study was to assess the knowledge, attitudes and the rules of proceeding concerning primary health care (PHC) doctors in the field of screening diagnostics for cognitive disorders in e...
The study included 175 PHC doctors. A validated anonymous questionnaire was used. The survey was conducted using the PAPI (Paper and Pencil Interviews) and CAWI (Computer Assisted Web Interviews) meth...
The vast majority of the respondents (n=159; 91.4%) saw the advisability of screening for cognitive disorders in the age group >65 years of age, but only 53 subjects (30.29%) believed that these tests...
Polish GPs are aware of the necessity of screening for cognitive disorders in seniors. Currently, there are no mechanisms within primary health care system that would enable proper early screening for...
Functional cognitive disorders (FCDs) are a common cause of subjective and mild cognitive impairment. Isolated FCDs commonly present to the cognitive clinic, but examination of the nature of the sympt...
Cognitive impairment is a core feature of mood disorders and has been identified as an important treatment target. A better understanding of the factors contributing to cognitive impairment in mood di...
Studies in adult samples examining the relationship between objective cognitive function and reported childhood trauma in major depressive disorder and/or bipolar disorder (in-episode or euthymia) wer...
Seventeen studies met the criteria for inclusion (mood disorders N = 1723, healthy controls N = 797). Evidence for childhood trauma being related to poorer cognitive functioning was consistent across ...
Findings from this review suggest childhood trauma is associated with poorer cognitive functioning in people with mood disorders. Targeted interventions to improve cognition may be warranted for this ...
Extensive literature has explored the beneficial effects of music in age-related cognitive disorders (ACD), but limited knowledge exists regarding its impact on gene expression. We analyzed transcript...